A Publication of the American Academy of Dermatology Association
SATURDAY • MARCH 4, 2017
Using value to reduce health costs
Acne guidelines clarify role of antibiotics
Exhibit hall floor plan and exhibitor listing4 10 Follow @AADmember on
Twitter! #AAD176
Four Late-breaking Research sessions presented today
The latest research in dermatology will be spotlighted in 48 abstracts that will be presented in
four two-hour sessions Saturday. The abstracts address the latest observations in clinical, surgical, and pediatric dermatology, as well as dermatopathology, therapeutics, and basic research.
Researchers were invited to submit abstracts describing their most recent results. The 48 abstracts were chosen from about 180 submitted. Those being presented received the top scores, and the authors will discuss their
findings in oral presentations during the sessions.
“Biologics and psoriasis continue to be very important,” Hensin Tsao, MD, PhD, director of the sessions, said of the abstracts submitted. “We are seeing atopic
dermatitis coming into the picture in the past couple of years, and this year in particular we are seeing a lot of interesting pediatric studies come out,” he said.
The schedule of Late-breaking Research sessions:• Clinical Trials (F056), 9-11 a.m.
in Room W415D• Clinical Studies/Pediatric (F072),
1-3 p.m. in Room W308A• Procedural Dermatology (F073),
1-3 p.m. in Room 304C• Basic Science/Cutaneous Oncology/
Pathology (F085), 3:30-5:30 p.m. in Room 304A“There has been such enthusiasm
to put research into the forefront at the Annual Meeting with these Late-breaking Abstract sessions,” Dr. Tsao said. “More than ever, people realize that great science has been, and will continue to be, a vital part of our specialty. I am glad to see that the Late-breaking Abstract sessions are teeming with submissions. Dermatologic research is definitely generating a buzz at this meeting.”
See SUNSCREEN page 25
Questions about sunscreen persistMedia reports on effectiveness of sunscreens can confuse consumers
C onsumers often have questions about what kind of sunscreen to use and how to use it because of confusing reports.
Dermatologists need to be ready to confidently answer those questions. In the end, the best answer is that data show that using higher SPF sunscreens helps reduce the risk of skin cancer.
“Dermatologists have to understand reports about sunscreens in the media and understand their weaknesses so that when we talk to patients we can be objective,” Darrell Rigel, MD, MS, said in an interview about his Friday presentation, “Does High SPF Sunscreen Offer Better Protection?”
Consumer confusion arises from two annual reports published each May by Consumer Reports and the Environmental Working Group (EWG), said Dr. Rigel, clinical professor at the Ronald O. Perelman department of dermatology at the New York University School of Medicine. He spoke during “Photoprotection” (F043).
“Last year, Consumer Reports said that many sunscreens did not meet their SPF levels in its testing, which is different from the way the government does its testing. That is part of the issue, but the concern was that sunscreens were not meeting their rated SPF,” Dr. Rigel said.
In its report, the EWG lowered its scores of sunscreens if they had ingredients EWG determined to be detrimental or if they
were applied as a spray or a powder.“In that report, nobody had integrated
the data to make it be clinically relevant. Some of these reports are taken out of context in terms of risk,” he said. “The other thing is that the sunscreen products they do recommend, if you click on them, they go right to Amazon and they get click-through revenues for them.
“It is not an objective system, but consumers see it. It is important that we, as dermatologists, know this and explain that the rating system is done by looking at ingredients that may not be dangerous whatsoever. It is not really measuring how effective they are in terms of protecting you from sunburn,” Dr. Rigel said.
Another concern of consumers is the effectiveness of sunscreens in reducing the risk of cancer. That is a question answered by many prospective studies, including a recent study that showed regularly using sunscreens rated SPF 15 or greater reduced the risk of getting melanoma by one-third, he said.
Even though it is accepted that the greater the SPF the better, there has been a debate on whether to cap the SPF level at 50. SPF 50 blocks 98 percent of the sun’s rays while SPF 100 blocks 99 percent of the rays, but at a greater cost. In addition, the greater concentration of chemicals required for a greater SPF could lead to more allergic reactions.
An important factor in this analysis
is that most consumers do not apply sunscreen at the tested and recommended amounts, so it is not as effective as it could be, but under-applying a higher SPF sunscreen will still provide UV protection at a reasonable level. Dr. Rigel said he recently completed a prospective trial, which has not been published, that backs up this reasoning.
“It was a real-world usage study. This study definitively showed an advantage of SPF 100 over 50. The higher SPF sunscreens do make a difference and protect more effectively,” he said.
Dr. Rigel discussed other points about suncreens:
Hensin Tsao, MD, PhD
Darrell Rigel, MD, MS, discusses sunscreens during “Photoprotection.”
AmLactin® Alpha-Hydroxy Therapy contains more than 3X* the concentration of lactic acid, a powerful AHA, compared to other top-selling therapeutic moisturizers. Our powerful formulas deeply moisturize and boost the skin’s natural renewal process through gentle exfoliation.
Visit amlactin.com to learn more!
Relief for persistent dry skin!
3X*AHA
*Data on file. EW Competitor Comparison Study Results. June 2016.
Sunburn Alert: This product contains an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to sunburn.Be sun smart: Use sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterward.
100 College Road West, Princeton, NJ 08540AmLactin and ULTRAPLEX are registered trademarks of Upsher-Smith Laboratories, Inc.©2017 Fougera Pharmaceuticals Inc. All rights reserved.S-RSZ-1340164 01/2017
Brought to you by
Visit us at booth 1627
T:10.875”T:15”
B:11.125”B:15.25”
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 2017 3
Board of Directors
President-Elect Vice President-Elect Nominating Committee Member Representatives
Meet your 2017 slate of candidates
The American Academy of Dermatology has selected its candidates in this year’s election. The Nominating
Committee voted to present the following slate of candidates (listed in random order) to the membership for the 2017 Academy election of officers, directors, and Nominating Committee member representatives. Kenneth J.
Tomecki, MDGeorge J. Hruza, MD
Jane M. Grant-Kels, MD
Alice Gottlieb, MD, PhD
Stephen Mandy, MD
Dirk Elston, MD
Seemal R. Desai, MD
Adelaide A. Hebert, MD
Scott M. Dinehart, MD
Christen M. Mowad, MD
Diane S. Berson, MD
Seth L. Matarasso, MD
Abby S. Van Voorhees, MD
Bruce A. Brod, MD
Vol. 29, No 2 March 4, 2017
PresidentAbel Torres, MD, JD
Physician ReviewerMarta Van Beek, MD, MPH
Executive Director & CEOElaine Weiss, JD
Director, Creative and PublishingLara Graf
Associate Director, PublishingKatie Domanowski
Senior Manager, Dermatology WorldRichard Nelson, MS
Managing Editor, Special PublicationsDean Monti, MFA
Staff WriterDanielle Piquette
Lead DesignerNicole Torling
Senior Graphic DesignerTheresa Oloier
Printed in U.S.A. ©2017American Academy of
Dermatology Association930 E. Woodfield Road
Schaumburg, IL 60173-4729Phone (847) 330-0230; Fax (847) 330-0050
www.aad.org
Produced for the American Academy of Dermatology
by Ascend Integrated Media
Rhonda WickhamVice President of Content
Greg SackuvichEditor in Chief
Tim NordDesigner
www.ascendmedia.com
A Publication of the American Academy of Dermatology The future of dermatologyPlenary lectures to highlight advances in research, practice
A highlight of every AAD Annual Meeting is the Plenary, with its wealth of lectures addressing topics of interest
about dermatology around the world. The Plenary features four scientific and clinical lectures, an invited speaker, and addresses by Academy leaders.
Named lectures will address telemedicine, propranolol, cancer development, and psoriasis, and the Guest Speaker will discuss the threat of Ebola. The Plenary will also feature addresses by AAD President Abel Torres, MD, JD, MBA, and President-elect Henry Lim, MD, from 8 to 11:30 a.m. Sunday in the Chapin Theater.
Clarence S. Livingood, MD, Award and LectureshipBetter patient access is a key component of improved health care, and telemedicine is expected to play a key role, especially in dermatology. Telemedicine can be used to improve triage, urgent care, inpatient consultation, direct follow-up with patients, and patient monitoring.
Carrie L. Kovarik, MD, will examine the potential of these changes in technology when she presents “Telemedicine and the Future of Medicine.” She is an assistant professor of dermatology, dermatopathology, and infectious diseases at the University of Pennsylvania.
In her lecture, Dr. Kovarik will discuss recommendations for standard practices in telemedicine to ensure quality and the role of the specialty in telemedicine.
Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership LectureThe chance discovery of the positive effects of propranolol on complicated infantile hemangiomas was seen when a newborn was being treated for corticosteroid-induced myocardiopathy. Since 2014, the molecule has increasingly been used as a successful treatment for hemangiomas.
Christine Léauté-Labrèze, MD, will trace that evolution in “Propranolol in Infantile Hemangiomas: A Successful Drug Repurposing.” She is a pediatric dermatologist at Universitaire de Bordeaux in Bordeaux, France.
Lila and Murray Gruber Memorial Cancer Research Award and LectureshipThe treatment of melanomas has improved with an increased knowledge of how moles can evolve from precursor lesions to melanomas. The molecular makeup of melanocytic neoplasms is a key in that evolution.
In his lecture, “How Moles Become Cancer,” Boris C. Bastian, MD, PhD, will discuss his study of lesions
and melanoma. He is a professor of dermatology and pathology at the University of California, San Francisco.
Marion B. Sulzberger, MD, Memorial Award and LectureshipPsoriasis has been the focus of an increased number of studies, which have found that the condition is associated with major cardiovascular events, metabolism disorders, diabetes, end-stage renal disease, and mortality.
Learn more about this research when Joel M. Gelfand, MD, MSCE, presents “Getting to the Heart (and Other Comobidities) of Psoriasis.” He is a professor of dermatology and epidemiology and director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania.
Dr. Gelfand will discuss emerging observational and experimental studies in humans that are better defining the impact of systemic treatment of psoriasis on major health outcomes, such as cardiovascular events.
Guest SpeakerRear Admiral Jordan W. Tappero, MD, MPH, will present “The West African Ebola Epidemic and the Global Health Security Agenda.” He is a senior advisor for Global Health, Center for Global Health (CGH) at the Centers for Disease Control and Prevention.
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 20174
“I was in the New and Emerging Technologies session this morning, where there were many new things about melanoma and skin cancer. The problem with them is that there are very serious side effects, so we have to think hard about when to use them to treat the patients. There was also good information about sunscreens in the session.”
Cleire Pereira, MDBrasilia, Brazil
“The development of a new biologic for atopic dermatitis — dupilumab,
which works on IL-4. It has not been approved yet, but atopic dermatitis is something I see a lot, and we have only a limited
ability to control the condition.”
Paul Dunn, MDSpokane Valley, Washington
“I think it is about how dupilumab is going to pan out for atopic dermatitis. That is going to be exciting because there has been nothing new for atopic dermatitis in so long.”
Stephanie Weston, MBBSLondon, United Kingdom
“A better understanding of the pathways involved with eczema and atopic dermatitis, and the
development of new drugs that target these specifically, as opposed to the drugs we used to have. We are almost obligated to go back a bit to basic science to understand how these new medications work, but that gives us a much better understanding of the disease.”
Fernanda Bellodi-Schmidt, MDCincinnati, Ohio
Question of the day
What is the most exciting clinical development you’ve heard about recently?
Using value to reduce health costsMedical literature offers guidance in cost-effective treatments
I n a nation divided over the path of health care, there is one fact on which everyone agrees — it all costs too much. Trying to reduce
costs seems a Sisyphean task, so a better approach is to get better value.
A Friday session, “Value in Healthcare: Improving Outcomes and Decreasing Waste” (F033), explained how to read dermatology literature to learn more about the comparative effectiveness of treatments. Three speakers tackled questions such as, “Is it worth spending hundreds of dollars a month on a treatment that produces only modestly improved outcomes?” or “Does a patient on this medication need this much monitoring?”
“Cost-effectiveness is not about the money but it is about what you are getting for the money. It is not about the dollar amount and spending less, it is about spending smarter,” said session speaker Adewole (Ade) Adamson, MD, MPP. “We need to understand in what therapeutic and diagnostic situations you can be more cost-effective.”
Value can seem an abstract concept, but session director Joslyn S. Kirby, MD, an associate professor of dermatology at Penn State University, made it more concrete. She said value can be seen as an equation in which the outcome is divided by the cost.
“We need to understand both parts: the numerator and denominator,” she
said. “We need to know how to measure or assess outcomes, how to understand what a cost is, and where there is an opportunity to recoup some of the waste. We also need to be able to look at the literature, interpret it confidently, and make changes in our practice.”
As an example, recently published literature calls for reduced monitoring of patients using isotretinoin and spironolactone.
“In the last couple of years, there have been papers coming out showing that the side effects of isotretinoin are probably not as common as we think they are,” Dr. Kirby said. “Side effects to the medication that we monitor for with labs are most often seen at the beginning of treatment, and there are very few changes found later in the course of treatment. So there are opportunities to tailor our monitoring practices to what is seen in the data in the literature.”
Speaker Arash Mostaghimi, MD, MPA, MPH, an assistant professor of dermatology at Harvard Medical School, applied the same approach to spironolactone.
“The routine testing for hyperkalemia among young, healthy women taking spironolactone for acne is an unnecessary practice,” Dr. Mostaghimi said. “Eliminating testing reduces costs and removes barriers to using this cheap and effective drug.”
“We are going with where the data
is leading us, and it is leading us toward the idea that additional testing doesn’t necessarily mean additional safety for the patient. Every time we treat a patient, we need to think about why this test, why this drug, why this patient, and why right now? We need to challenge all of our assumptions.”
Dr. Adamson applied the same approach to the use of combination products for acne. Trials show the effectiveness of these products, but at a great cost over other approaches.
“What a lot of people do not look at in a study are the vehicle arm or the group that is not treated with the combination product or the single product,” said Dr. Adamson, an assistant professor of dermatology at the University of North Carolina School of Medicine. “What you don’t notice is that while there is a difference between combination products and vehicle — benzoyl peroxide in particular — that difference is really small.
“If you look at the price comparing benzoyl peroxide to combination products or monotherapy, there is really only a small difference in how much better people get. You may pay $200, $300, or $500 more to get a 5-10 percent benefit. In practice, that may only be a difference of 4 or 5 pimples at a cost of $500. Is that worth it?” Physicians should use GoodRx to check the prices of medications and look for ways to stay current on their reading, Dr. Adamson said.
“In dermatology, there is no easy resource to be able to determine that. I hope with this discussion that we can create a hub or database where this can be found more quickly.”
Adewole (Ade) Adamson, MD, MPP, talks about increasing the value of health care as his fellow speakers, Joslyn S. Kirby, MD, and Arash Mostaghimi, MD, MPA, MPH, listen.
PREPARED BY FCB
Job #: 10687590Releasing as: Native file Production: S. Curry x3029
Colors: 4C AD: C. Anderson
Client: Pfizer AE:
Product: Eucrisa Bleed: 11.125”w x 15.25”h Producer: L. Burgess
Client Code: Trim: 10.875"w x 15"h QC: L.Powell
Date: January 19, 2017 5:44 PM Safety: 10.375"w x 14.5"w Digital Artist: tp,BD, tp, BB, tp,BD
Proof: M6FRAdd’l Info:
Fonts: Co Text M1 Spellcheck: M. Benedetto
FR Spellcheck: Luigi Mennella
Path: PrePress:Pfizer:Eucrisa:10687590:_PACKAGED:10687590_AAD_Annual_Mtg_News:10687590_AAD_Annual_Mtg_News_M6FR
4C Eucrisa AAD Annual Meeting News Ad
AAD food court
Entrance to convention hall
at booth #2589
Now Approved!Connect•the•dots to learn more
PP-CRI-USA-0201 © 2017 Pfizer Inc. All rights reserved. Printed in USA/January 2017
S:10.375”S:14.5”
T:10.875”T:15”
B:11.125”B:15.25”
10687590_AAD_Annual_Mtg_News_M6FR.indd 1 1/19/17 5:52 PM
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 20176
Vote online at aad.org/aadelection or from the 2017 AAD Annual Meeting Mobile App
Exercise your member right to vote. The leaders of today will influence how
you practice medicine tomorrow.
TELEMEDICINE
SCOPE-OF-PRACTICE
NETWORK ADEQUACY AND TRANSPARENCY
PHYSICIAN PAYMENT REFORM
ACCESS TO DERMATOPATHOLOGY SERVICES
PATIENT ACCESS TO DRUGS/TREATMENTS
NEW VOTING TIMELINE
OPENSMarch 4
CLOSESMarch 18
What’s weighing on YOUR mind?
NEW Election Voting Timeline March 4 – 18
Acne guidelines clarify role of antibiotics with topical therapy
T he highlights of AAD Guidelines of Care for the Management of Acne Vulgaris, including the use of antibiotics,
isotretinoin, hormonal therapy, and physical modalities, as well as the role of diet in acne, will be reviewed during an education session Saturday morning.
“The audience and others in practice
ask: Will this restrict what they are able to do? That is not the intent of guidelines. The intent of the guidelines is to review the literature to see what data are available based on current evidence and then provide recommendations in line with that evidence that would be directly applicable to various clinical scenarios,” said the session director, Bethanee J. Schlosser,
MD, PhD. She was also a member of the workgroup that wrote the guidelines, published last year (J Am Acad Dermatol 2016; 74(5):945-973).
One of the clinical guideline’s strongest statements is on antibiotic therapy, which should not
be used alone, whether it is a topical or systemic antibiotic, said Dr. Schlosser, an associate professor in the department of dermatology at Northwestern University Feinberg School of Medicine.
“If patients do need antibiotics,” she said, “they should always be used in
conjunction with a topical therapy, such as benzoyl peroxide, to decrease antibiotic resistance. A retinoid should also be used to enable patients to more quickly decrease or get off antibiotic therapy.
“The guidelines suggest that after initiating an oral antibiotic, patients should be evaluated at three months.”
The guidelines clarify the use of isotretinoin and its dosing strategies, which will be reviewed in the session. They also address concerns about potential links between isotretinoin and inflammatory bowel disease, depression, and mood disorders while advocating for the monitoring of individual patients for depression and mood disorders, Dr. Schlosser said.
Data regarding hormonal therapy for acne is plentiful, with no one oral contraceptive pill standing apart from others. The discussion of hormonal therapy will also address appropriate patient selection and the use of spironolactone as an off-label treatment for acne.
The role of diet in acne still is not clear, with no obvious dietary triggers in most patients, Dr. Schlosser said. However, the presentation will look at data that reviews a high glycemic index and skim milk in dairy products as possible triggers for acne.
The final presentation will explore physical modalities, such as chemical peels, lasers, and light therapy, but the guidelines note too much variability in procedures and outcomes to advocate their use, she said.
“The guidelines do recommend that you can consider those physical modalities of treatment as adjuvant in patients with acne or those who are not eligible for other therapies, but they should not replace standard-of-care therapy,” Dr. Schlosser said.
Most importantly, the new guideline recommendations differ from the previous guidelines by advocating for a greater emphasis on using topical retinoids both during and following oral antibiotics as maintenance therapy, she said.
“The guidelines are most helpful in terms of identifying what gaps there are in terms of the evidence in existence. They are not supposed to handcuff anyone, but are supposed to provide guidance,” Dr. Scholsser said.
To learn more about the acne guidelines, visit www.aad.org/dw/monthly/2015/august/overusing-acne-antibiotics.
Translating Evidence Into Practice: Acne Guidelines (F048)
9-11 a.m. Saturday
Room W304A
W I N N I N G
P E P T I D E S
A W A R D -
peptide-rich serum for expression lines
Contains multiple layers of new technologyfor reducing the appearance of expression linesaround the eyes, forehead and mouth.
• Formulated with clinical levels of 7 peptides, including two award-winning peptides
• Targets the appearance of 7 types of expression lines
• Keeps skin looking relaxed without losing the ability to express yourself
I N T R O D U C I N G
Visit us at booth #1241. 800.385.6652 revisionskincare.com.
New breakthrough
formula is changing the face
of expression lines.
*Data on file. Results may vary.
Before After 8 weeks*
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 20178
Breaking News
Preventing burnoutSpeakers to discuss causes, strategies
S peakers will address the factors contributing to frustration and anxiety for today’s dermatologists.
Panelists in the Monday session will explore the silent epidemic of physician burnout and discuss strategies to prevent, identify, and mitigate it for dermatologists.
“This is a groundbreaking discussion for our profession,” said J. Matthew Knight, MD, session director. “Although
dermatologists historically do better than our peers when it comes to job satisfaction, unprecedented bureaucracy coupled with feelings of worthlessness and fatigue are leading to troubling levels of professional burnout in our ranks. This is a unique and important session for any practicing dermatologist.”
Bureaucracy, Compliance, and Burnout: What it Means to Dermatologists (U084)
7:30-8:30 a.m. Monday
Room W315A
Download the new AAD Meeting Mobile App
I t’s back … and better than ever! The AAD Meeting
Mobile App has been redesigned for optimum functionality and easier navigation at the 2017 AAD Annual Meeting. Please note that the old AAD Meetings Mobile App (with the blue AAD logo) is now officially inactive, so you must download the new app with the white AAD logo in the iPhone App store or Google Play.
Overall, the new app will offer the same features as the previous app, which includes the following:• Session Schedule: Listing of sessions
by day, type, category, and speaker; bookmark sessions you like, take notes, or access select session handouts
• Exhibitors: Search by name or category, or view the exhibit hall floor plan
• Speakers: Search by name to see what session they are speaking in
• Maps: Explore floor plans for session rooms
• Ask Me: Discover answers to frequently asked questions• Event listing: Council, Committee, Task Force meetings, Affiliate and Reunion Groups, Industry Expert Sessions, and Industry Non-CME (INC) Programs (previously known as PIPs)• E-Posters: Access e-Posters; search by author, title, category, keyword, or poster number• Audience Response: Access Audience Response Sessions and participate via your mobile device
For instructions, visit www.aad.org/mobile for links on how to
download the app for iPhone and Android smartphones. You may also search “AAD Meetings” in the iPhone App store or Google Play and download the app with the white AAD logo icon.
If you have questions or concerns while at the meeting, visit one of the two Mobile App assistance desks at the Orange County Convention Center in West Lobby B, Level 1, or at The Connection, Hall B4. Both desks will be open Friday through Monday from 7 a.m. to 5:30 p.m.
FAQs
Schedule Exhibitors
Maps
Speakers
CME/Evaluations
Event ListingSearch
Audience Response
2017 AAD Annual Meeting
Orlando, FL • March 3-7, 2017
ORANGE COUNTY CONVENTION CENTER
The Annual Meeting opensThe 2017 AAD Annual Meeting opened Friday with large crowds filling the hallways and registration area of the Orange County Conven-tion Center. The excitement flowed over into the Exhibit Hall, where attendees thronged to see the prod-ucts and services of more than 400 exhibitors. The Annual Meeting will continue through Tuesday.
WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS.
WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS. BUT UNDERSTANDING HOW THEY’RE FEELING, AND WHAT THEY’RE FEELING, EVERY DAY. LET’S PLEDGE OUR COMMITMENT TO SUPPORT, ENCOURAGE AND EMPOWER OUR PATIENTS TO TAKE ACTION. TOGETHER, WE CAN CHAMPION THEIR PROGRESS. WE’RE HERE TO STAND UP FOR PATIENTS. AND IT STARTS BY LISTENING TO THEM. NOT SIMPLY HEARING THEIR SYMPTOMS.
©2017 AbbVie Inc. North Chicago, IL 60064 64V-1891925 January 2017 Printed in U.S.A.
IT ONLY TAKES A MINUTE TO MAKE A DIFFERENCETake a quiz. Take a photo. AbbVie will make a donation to AAD’s Camp Discovery for your participation and commitment to patients.
VISIT ABBVIE BOOTH 2053
64V-1891925_2017_AAD_DailyNews_Pledge.indd 2 1/18/17 3:06 PM
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201710
#21st Century Oncology ..................................35303Gen Inc./DermLite ......................................26355CC (5-Continent-Congress) ..........................2079
AAbbVie ...............................................2053, 2441 Accredo ........................................................2178Accurate Manufacturing Inc. .........................3271AccuTEC Blades ............................................1965AccuVein ......................................................1070Aclaris Therapeutics Inc. ...............................3526Actelion Pharmaceuticals US ........................2664Action Bag Co. ..............................................1766Acuderm.......................................................2219AD Surgical ..................................................1692Adako USA ...................................................3187Advalight ......................................................1679Advanced Dermatology & Cosmetic
Surgery .....................................................3215Advanced MD Inc. ........................................2177Advanced Rad Solutions ................................1058Advanced Skin & Hair ...................................1360
Advanced Technology Laser Co. Ltd. ..............3192Aerolase ........................................................1521Aesthetic Guide, The .....................................1335Agnes formerly Gowoonsesang Cosmetics ....1265Allergan ........................................................2253Allied Powers LLC .........................................3389Allina Health ................................................3588Alma Lasers ..................................................2461American Board of Dermatology ...................3134American College of Phlebology ....................3491American Society for
Dermatologic Surgery ...............................2426American Society for Mohs Surgery ...............2723Amgen Inc. ...................................................2553AMP Medical Products LLC ..........................3412Anne Arundel Dermatology, P.A. ...................3391AnteAGE MD by Cellese ...............................1081Anthony Products/Gio Pelle ..........................3305Anutra Medical .............................................3558AP Easy Software Solutions ...........................1038AP Medesthetics Inc./VeinGogh ....................3493Aqua Pharmaceuticals ...................................1339Aquavit Pharmaceuticals Inc. ........................2381Ascentium Capital LLC .................................1036Asclepion Laser Technologies ........................1533Asembia LLC ................................................1062
Aubio Life Sciences .......................................3386Aurora Diagnostics .......................................1041AzaClear .......................................................3566
BBako Integrated Physician Solutions ..............1128Bank of America Practice Solutions ...............1264Bayer ............................................................2041Baylor Scott & White Health ..........................1567Beiersdorf Inc. ..............................................2753Beijing Sincoheren
S&T Development Co. Ltd. ........................3458Beijing Syntech Laser Co. Ltd. .......................3074Bellaire Industry/Mesopen ............................2977Benev Co. Inc. ..............................................3075Bio-Oil ..........................................................2375Biodermis ...........................................2431, 3293 Biofrontera Inc..............................................3579Biogenix Skin Sciences ..................................1186Biologica Technologies ..................................1040Biomed Diagnostics ......................................3388Biopelle Inc. .................................................1919BioPharmX ...................................................3390Bios SRL .......................................................1390bioskin GmbH ..............................................1261
Blaine Labs Inc. ............................................3416Bloq-UV .......................................................1691Boehringer Ingelheim
Pharmaceuticals Inc. .................................3527Bovie Medical ...............................................2371brandMD Skin Care ......................................3453Brazilian Society
for Dermatological Surgery ........................2475Brymill Cryogenic Systems ............................2226BTL ..............................................................1133
CCabana Life ...................................................3543Caliber Imaging & Diagnostics ......................1866Canfield Scientific .........................................1927Capillus LLC .................................................2683CareCredit ....................................................1127CarePath Diagnostics ....................................1768Carismed GmbH ..........................................1071Castle Biosciences Inc. ..................................1110Celgene Corp. ...............................................1053Centura Pharmaceuticals Inc. ........................1064Chemistry Rx ................................................2884Chemotechnique Diagnostics/
Dormer Laboratories .................................1662
Annual Meeting exhibitors Listing as of Feb. 14. For the most up-to-date listing, go to show.aad.org/annual17/ec/forms/attendee/indexTab.aspx
1004 1005
1006
1008
1011
1012 1013
1014 1015
1016 1017
1019
1020 1021
1023
1026 1027
1029
1030 1031
1032
1035
1036
1038
1040 1041
1044
1052 1053
1054
1056
1058
1060
1062
1064 1065
1066
1068
1070 1071
1074 1075
1076
1078
1080 1081
1082 1083
1084 1085
1086 1087
1088
1090 1091
1092
1105
1110
1114 1115
1116
1118
1120 1121
1126 1127
1128
1130
1133
1165
1169
1170
1175
1177
1180 1181
1182 1183
1186 1187
1193
1205
1207
1213
1219
1231
1241
1253
1261
1264 1265
1266
1270
1274 1275
1278
1281
1282
1286 1287
1288 1289
1290 1291
1293
1304 1305
1308
1313
1319
1327
1329
1331
1335
1339
1353
1360 1361
1366 1367
1375
1377
1381
1386
1389
1390
1426 1427
1432 1433
1439
1461
1469
1474 1475
1476
1481
1489
1505
1515
1521
1527
1529
1533
1539
1553
1563
1567
1569
1575
1577
1581
1589
1591
1593
1605
1619
1626 1627
1635
1653 1661
1662
1666 1667
1668
1671
1674 1675
1676
1679
1683
1688 1689
1691
1692 1693
1719
1766 1767
1768 1769
1770 1771
1774 1775
1778
1783
1788
1819
1831
1866 1867
1870
1875
1877
1919
1927
1930
1937
1953
1960 1961
1965
1966
1969
1974 1975
1978
20002005
2019
2027
2035
2041
2053
2060
2064
2069
2074 2075
2078 2079
2127
2135
2174 2175
2177
2178
2219
2226 2227
2231
2253
2271
2274 2275
2276
2319
2326 2327
2370 2371
2375
2379
2381
2383
2389
2405
2417
2426
2431
2435
2441
2453
2461
2470
2474 2475
2478
2482 2483
2489
2505
2523
2527
2530
2535
2536
2541
2553
2565
2567
2575
2581
2583
2589
2622 2623
2635
2664 2665
2675
2680
2683
2684
2722 2723
2727
2735
2741
2753
2767
2775
2781
2785
2787
2791
2805
2822
2827
2834 2835
2867
2875
2880
2883
2884
2886
2889
2922 2923
2953
2963
2969
2971
2975
2977
2981
2989
3005
3015
3022
3031
3035
3041
3062 3063
3068
3074 3075
3081
3089
3127
3130
3134
3153
3161
3163
3169
3175
3187
3188
3191
3192
3205
3211
3215
3219
3221
3239
3260 3261
3264
3267
3269
3271
3286 3287
3291
3293
3305
3310
3313
3314 3315
3318
3320 3321
3327
3333
3343
3353
3359
3363
3365
3366
3368 3369
3375
3381
3386 3387
3388 3389
3390 3391
3404 3405
3406 3407
3408
3410
3412 3413
3414
3416
3419
3423
3427
3435
3445
3453
3458 3459
3460 3461
3462
3464 3465
3469
3471
3475
3481
3486 3487
3488 3489
3491
3492 3493
3504 3505
3508 3509
3513
3515
3518 3519
3520
3523
3526 3527
3528
3530 3531
3533
3537
3541
3543
3544 3545
3553
3557
3558 3559
3563
3564
3566 3567
3570 3571
3575
3579
3581
3583
3585
3586 3587
3588 3589
3590 3591
733
Roo
m
Roo
m 4
05R
oom
409
Roo
m 4
13R
oom
417
Roo
m 4
21R
oom
429
Roo
m 4
33R
oom
437
Roo
m 4
41R
oom
445
Roo
m 4
53R
oom
457
Roo
m 4
61R
oom
465
Roo
m 4
69
Roo
m 5
04
Roo
m 5
05
Roo
m 5
08
Roo
m 5
09
Roo
m 5
12
Roo
m 5
13
Roo
m 5
16
Roo
m 5
17
Roo
m 5
20
Roo
m 5
21
Roo
m 5
28
Roo
m 5
29
Roo
m 5
32
Roo
m 5
33
Roo
m 5
36
Roo
m 5
37
Roo
m 5
40
Roo
m 5
41
Roo
m 5
44
Roo
m 5
45
Roo
m 5
52
Roo
m 5
53
Roo
m 5
56
Roo
m 5
57
Roo
m 5
60
Roo
m 5
61
Roo
m 5
64
Roo
m 5
65
Roo
m 5
68
Roo
m 5
69
Roo
m 6
04R
oom
608
Roo
m 6
12R
oom
616
Roo
m 6
20R
oom
628
Roo
m 6
32R
oom
636
Roo
m 6
40R
oom
644
Roo
m 6
52R
oom
656
Roo
m 6
60R
oom
668
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
FX FX
FX
FX
FHC
FX
FX
FX
FX
FX
FX
FX FX
FX
FXFHC
FX
FX FX FX FX FX FX FX FX
FHC FXFHCFXFHCFHCFHC
FX
FHB
EXIT EXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXIT
EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT
HALL WB4 ENTRANCEHALL WB2 & WB3 ENTRANCE
HALL WA4 ENTRANCE HALL WB1 ENTRANCE
HALL WA3 ENTRANCEHALL WA2 ENTRANCEHALL WA1 ENTRANCE
30'10'10'10'
18'9'3"9'4"
18'
10'76'
10'
27'10'
17'6"7'8"
19'10' 10'
17'6"8'
10'19'
10'FI
RE
DO
OR
DO
NO
T BL
OC
K39' 39'39'2"39'2"
16'-6"10'
10'-8"
10' 10'
5'5"
10'
16'-6"10'
10'-8" 16'-6"10'
10'-8"10'
18'-6" 34' 10'-7"10'
46'-4" 46'-5" 10'-7" 30'-8"11'-4"
WA1 WA2 WA3 WA4 WB1 WB2 WB3 WB4
WF WF WF WF WF WF WF WF WF WF WF
WFWF
WF
UPDN
UPUP
DIRECTIONAL
DIRECTIONAL
DIRECTIONAL
DIRECTIONAL
FIR
E D
OO
RD
O N
OT
BLO
CK
BLO
CK
DO
NO
T
#4 #5 #6 #7Seating Area Seating Area Seating Area Seating Area8'
21'
27'
8'21'
8'21'
8'21'
27'TILED FLOOR AREA TILED FLOOR AREA
TILED FLOOR AREA TILED FLOOR AREA
TILED FLOOR AREA TILED FLOOR AREA
L2-01A
L2-0
1B
L2-03
L2-04A L2-04B
L2-05
L2-06L2-07
L2-09B L2-09A
L2-10 L2-14
L2-15A L2-15B
L2-12L2-13
L2-17A L2-17B
L2-16A L2-16B L2-16C L2-16D L2-16EL2-18
L2-23
L2-19
L2-20A
L2-20C
L2-20B
L2-24A L2-24B
L2-26A L2-26CL2-26B
L2-21 L2-22 L2-28A L2-28BL2-29 L2-34
L2-25A L2-25B
L2-32L2-33
L2-37A L2-37B
L2-36A L2-36B L2-36C L2-36D L2-36EL2-41
L2-39L2-40
L2-38 L2-42 L2-43
@75.625" @76" @75.75"
NOTMEASURED
(HAD MIS WRAP)
0001
0002
PR
IVA
TE E
XP
O M
EE
TIN
G S
UIT
ES
INDUSTRYEXPERT
SESSIONS
FOOD COURT
AADTHE CONNECTION
(e-Posters andPresentations,AAD Resource
Center,Networking
Center/e-Center)
EXHIBITS
▲
2018SPACE
SELECTIONOFFICE
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 2017 11
Continued on page 12
Map
1004 1005
1006
1008
1011
1012 1013
1014 1015
1016 1017
1019
1020 1021
1023
1026 1027
1029
1030 1031
1032
1035
1036
1038
1040 1041
1044
1052 1053
1054
1056
1058
1060
1062
1064 1065
1066
1068
1070 1071
1074 1075
1076
1078
1080 1081
1082 1083
1084 1085
1086 1087
1088
1090 1091
1092
1105
1110
1114 1115
1116
1118
1120 1121
1126 1127
1128
1130
1133
1165
1169
1170
1175
1177
1180 1181
1182 1183
1186 1187
1193
1205
1207
1213
1219
1231
1241
1253
1261
1264 1265
1266
1270
1274 1275
1278
1281
1282
1286 1287
1288 1289
1290 1291
1293
1304 1305
1308
1313
1319
1327
1329
1331
1335
1339
1353
1360 1361
1366 1367
1375
1377
1381
1386
1389
1390
1426 1427
1432 1433
1439
1461
1469
1474 1475
1476
1481
1489
1505
1515
1521
1527
1529
1533
1539
1553
1563
1567
1569
1575
1577
1581
1589
1591
1593
1605
1619
1626 1627
1635
1653 1661
1662
1666 1667
1668
1671
1674 1675
1676
1679
1683
1688 1689
1691
1692 1693
1719
1766 1767
1768 1769
1770 1771
1774 1775
1778
1783
1788
1819
1831
1866 1867
1870
1875
1877
1919
1927
1930
1937
1953
1960 1961
1965
1966
1969
1974 1975
1978
20002005
2019
2027
2035
2041
2053
2060
2064
2069
2074 2075
2078 2079
2127
2135
2174 2175
2177
2178
2219
2226 2227
2231
2253
2271
2274 2275
2276
2319
2326 2327
2370 2371
2375
2379
2381
2383
2389
2405
2417
2426
2431
2435
2441
2453
2461
2470
2474 2475
2478
2482 2483
2489
2505
2523
2527
2530
2535
2536
2541
2553
2565
2567
2575
2581
2583
2589
2622 2623
2635
2664 2665
2675
2680
2683
2684
2722 2723
2727
2735
2741
2753
2767
2775
2781
2785
2787
2791
2805
2822
2827
2834 2835
2867
2875
2880
2883
2884
2886
2889
2922 2923
2953
2963
2969
2971
2975
2977
2981
2989
3005
3015
3022
3031
3035
3041
3062 3063
3068
3074 3075
3081
3089
3127
3130
3134
3153
3161
3163
3169
3175
3187
3188
3191
3192
3205
3211
3215
3219
3221
3239
3260 3261
3264
3267
3269
3271
3286 3287
3291
3293
3305
3310
3313
3314 3315
3318
3320 3321
3327
3333
3343
3353
3359
3363
3365
3366
3368 3369
3375
3381
3386 3387
3388 3389
3390 3391
3404 3405
3406 3407
3408
3410
3412 3413
3414
3416
3419
3423
3427
3435
3445
3453
3458 3459
3460 3461
3462
3464 3465
3469
3471
3475
3481
3486 3487
3488 3489
3491
3492 3493
3504 3505
3508 3509
3513
3515
3518 3519
3520
3523
3526 3527
3528
3530 3531
3533
3537
3541
3543
3544 3545
3553
3557
3558 3559
3563
3564
3566 3567
3570 3571
3575
3579
3581
3583
3585
3586 3587
3588 3589
3590 3591
733
Roo
m
Roo
m 4
05R
oom
409
Roo
m 4
13R
oom
417
Roo
m 4
21R
oom
429
Roo
m 4
33R
oom
437
Roo
m 4
41R
oom
445
Roo
m 4
53R
oom
457
Roo
m 4
61R
oom
465
Roo
m 4
69
Roo
m 5
04
Roo
m 5
05
Roo
m 5
08
Roo
m 5
09
Roo
m 5
12
Roo
m 5
13
Roo
m 5
16
Roo
m 5
17
Roo
m 5
20
Roo
m 5
21
Roo
m 5
28
Roo
m 5
29
Roo
m 5
32
Roo
m 5
33
Roo
m 5
36
Roo
m 5
37
Roo
m 5
40
Roo
m 5
41
Roo
m 5
44
Roo
m 5
45
Roo
m 5
52
Roo
m 5
53
Roo
m 5
56
Roo
m 5
57
Roo
m 5
60
Roo
m 5
61
Roo
m 5
64
Roo
m 5
65
Roo
m 5
68
Roo
m 5
69
Roo
m 6
04R
oom
608
Roo
m 6
12R
oom
616
Roo
m 6
20R
oom
628
Roo
m 6
32R
oom
636
Roo
m 6
40R
oom
644
Roo
m 6
52R
oom
656
Roo
m 6
60R
oom
668
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
SEATING AREA
PLAN
TER
FX FX
FX
FX
FHC
FX
FX
FX
FX
FX
FX
FX FX
FX
FXFHC
FX
FX FX FX FX FX FX FX FX
FHC FXFHCFXFHCFHCFHC
FX
FHB
EXIT EXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXITEXIT
EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT EXIT
HALL WB4 ENTRANCEHALL WB2 & WB3 ENTRANCE
HALL WA4 ENTRANCE HALL WB1 ENTRANCE
HALL WA3 ENTRANCEHALL WA2 ENTRANCEHALL WA1 ENTRANCE
30'10'10'10'
18'9'3"9'4"
18'
10'76'
10'
27'10'
17'6"7'8"
19'10' 10'
17'6"8'
10'19'
10'
FIR
E D
OO
RD
O N
OT
BLO
CK
39' 39'39'2"39'2"
16'-6"10'
10'-8"
10' 10'
5'5"
10'
16'-6"10'
10'-8" 16'-6"10'
10'-8"10'
18'-6" 34' 10'-7"10'
46'-4" 46'-5" 10'-7" 30'-8"11'-4"
WA1 WA2 WA3 WA4 WB1 WB2 WB3 WB4
WF WF WF WF WF WF WF WF WF WF WF
WFWF
WF
UPDN
UPUP
DIRECTIONAL
DIRECTIONAL
DIRECTIONAL
DIRECTIONAL
FIR
E D
OO
RD
O N
OT
BLO
CK
BLO
CK
DO
NO
T
#4 #5 #6 #7Seating Area Seating Area Seating Area Seating Area8'
21'
27'
8'21'
8'21'
8'21'
27'TILED FLOOR AREA TILED FLOOR AREA
TILED FLOOR AREA TILED FLOOR AREA
TILED FLOOR AREA TILED FLOOR AREA
L2-01A
L2-0
1B
L2-03
L2-04A L2-04B
L2-05
L2-06L2-07
L2-09B L2-09A
L2-10 L2-14
L2-15A L2-15B
L2-12L2-13
L2-17A L2-17B
L2-16A L2-16B L2-16C L2-16D L2-16EL2-18
L2-23
L2-19
L2-20A
L2-20C
L2-20B
L2-24A L2-24B
L2-26A L2-26CL2-26B
L2-21 L2-22 L2-28A L2-28BL2-29 L2-34
L2-25A L2-25B
L2-32L2-33
L2-37A L2-37B
L2-36A L2-36B L2-36C L2-36D L2-36EL2-41
L2-39L2-40
L2-38 L2-42 L2-43
@75.625" @76" @75.75"
NOTMEASURED
(HAD MIS WRAP)
0001
0002
PR
IVA
TE E
XP
O M
EE
TIN
G S
UIT
ES
INDUSTRYEXPERT
SESSIONS
FOOD COURT
AADTHE CONNECTION
(e-Posters andPresentations,AAD Resource
Center,Networking
Center/e-Center)
EXHIBITS
▲
2018SPACE
SELECTIONOFFICE
Circadia by Dr. Pugliese ................................2478Clinical Resolution Lab Inc. ...........................1867CLN Skin Care (TopMD Skin Care) ...............1114CNH Pillow Inc. ...........................................3219Coalition of Skin Diseases .............................2735Cobalt Medical Supply Inc. ............................1115CoLabs International Corp. ...........................3419Collagen P.I.N. ..............................................1688Compulink Business Systems Inc. .................2675Coolibar, Sun Protection You Wear ................1432Corrona LLC .................................................1676Cortex Technology Aps ..................................2622CosMedical Technologies LLC .......................2470Cosmofrance Inc. ..........................................3553CPa Medical Billing .......................................2971CRC Press - Taylor & Francis .........................1563Crown Laboratories Inc. ................................2435CryoProbe ....................................................1054Crystal Clear Digital Marketing .....................3508Cu-Tech ........................................................1213CureMD Healthcare ......................................2074Cutanea Life Sciences Inc. .............................2889Cutera ..........................................................2527Cutis & Cosmetic Dermatology .....................1767Cynosure ......................................................1439Cynova Laboratories ......................................1183
DD-Path Dermatopathology .............................3359Daavlin .........................................................3153DANA ..........................................................3492DefenAge .....................................................1286DEKA Medical ..............................................1469Delasco .........................................................1505Demandforce Inc. .........................................1004Derm101 .......................................................2923Derma Faith LLC ..........................................3575Dermablend .................................................1960DermapenWorld-Equipmed USA ..................2583DermaSweep ................................................2075Dermatologic Cosmetic Laboratories .............1427Dermatologist, The .......................................2822Dermatology Associates ................................3460Dermatology Foundation ..............................3310Dermatology News ........................................1769Dermatology Solutions Group .......................1788Dermatology Times ......................................1527DermLink Inc. ..............................................2581DermOne LLC ..............................................1056DermoScan GmbH .......................................1377Dermpath Diagnostics ..................................1353Dermpath Lab of Central States .....................3327DermResources LLC .....................................2370DermTech ....................................................2276Dermwise .....................................................3541
Designs for Vision Inc...................................2078Dino-Lite Scopes (BigC) ................................1575Dow Development Laboratories .....................3408Dr. Marder Skincare ......................................3583DRE Medical Inc. ..........................................3464
EeClinicalWorks..............................................1877Eclipse Aesthetics LLC ..................................2875Elekta ...........................................................3509Ellipse Inc. ....................................................1023Ellis Instruments ..........................................1626ELON Hair, Nails & Skin ...............................3188Elsevier .........................................................3205EltaMD SkinCare ................................1026, 1319Emirates Dermatology Society .......................1770Emvera Technologies LLC .............................1978EndyMed Medical Ltd. ...................................2981Envy Medical ................................................1219Epionce ........................................................1775Erchonia Corp. ..............................................1953eRelevance Corp. ..........................................1029Espada Dermatology .....................................1778EunSung Global Corp. ..................................3169Euro-Asian Association
of Dermatovenerologists ...........................1021European Academy of Dermatology
and Venereology .......................................0001
Exeltis USA...................................................3531EZDerm LLC ................................................1005
FFeel Good Inc. ....................................3585, 1076Ferndale Healthcare Inc. ...............................2319FibroTx LLC ..................................................1170FIGS ............................................................1281FineMec Co. Ltd. ...........................................1169Focus Medical ...............................................2775Forefront Dermatology ..................................2781Fotofinder Systems Inc. .................................1969Fotona Lasers ................................................1105
GGalderma Laboratories, LP ............................1605Genentech, a Member of the Roche Group ....1305Gensco .........................................................1175GliSODin Skin Nutrients ..............................1474GlitterTots ....................................................1180Glowbiotics MD ............................................2383Gold Bond Ultimate ......................................3475Grand Aespio Inc. .........................................3471Group Health Physicians ...............................3318Guangzhou Huafei Tongda
Technology Co. Ltd....................................1289
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201712
Continued from page 11
Many SK patients feel embarrassed about their skin, worry about looking older, and struggle to cover, disguise or deal with the condition.1 SK matters to patients and impacts their daily lives.1
The majority of patients with SK are interested in a treatment option that is unlikely to scar and does not involve cutting, burning or freezing.1
Learn more at booth #3526 and SKMatters.com
MORE THAN 83 MILLION AMERICANS HAVE SK.2
83 OF SK PATIENTSARE INTERESTED IN TREATMENTand willing to pay out-of-pocket1
%
1Data on File. Aclaris Therapeutics SK In-offi ce Observational Study, 406 dermatology patients, 2016. 2 Bickers DR, et al. The burden of skin diseases: 2004. J Am Acad Dermatol 2006; 55:490-500.
© 2017 Aclaris Therapeutics Inc. All Rights Reserved.
HHaircheck .....................................................3423HairMax-Lexington International...................1675Hankins Consulting ......................................1066Hans Biomed USA Inc. .................................1078Hansderma ...................................................3518Hayden Medical Instruments ........................1870Healio Dermatology ......................................1090Heine USA Ltd. ............................................3161Henry Schein ................................................1274Hidrex USA ..................................................3414Hill Dermaceuticals Inc. ...............................1426Hill Laboratories Co. .....................................3427Hill Top Research .........................................1831Hironic Co. Ltd. ............................................1288Horus-Adamo SRL ........................................1177HRA Healthcare Research & Analytics ..........1116Hy-Tape International ...................................1019HydraFacial MD - Edge Systems LLC .............1515HydroPeptide ...............................................2483
IIagnosis Inc./DermatologistOnCall ...............3363Ibero Latin American College of
Dermatology/CILAD .................................1689IFC SA .........................................................1381ILOODA Co. Ltd. ..........................................1187Image Skincare .............................................1275Infinity Massage Chairs.................................3488Innovaderm Research ...................................1165Innovative Optics Laser Eye Protection ..........2326Innovative Skincare .......................................1489Integrated Dermatology Group ...........2767, 3022Interderma, S.L. ............................................3366International Society of Dermatology .............3313
Irmat Pharmacy ............................................3459ISDIN.................................................2389, 2489
JJAMA Network, The ......................................3405Jan Marini Skin Research ..............................2535Janssen Biotech, Inc. .....................................3005JILIN PROVINCE KING LASER
TECHNOLOGY CO. LTD...........................2886Johnson & Johnson Consumer Inc. ...............2805Journal of Clinical and Aesthetic
Dermatology .............................................2565Journey Medical Corp. ...................................3462JP Medical Publisher .....................................1044
KKaiser Permanente ........................................3035Kao USA Inc. ................................................3333Karger Publishers .........................................1205KCD Medical ................................................1966Kernel Medical ..............................................1375
LLa Roche-Posay .............................................1661Laboratoires Filorga ......................................3375LASERING SRL ............................................3321Laseroptek Co. Ltd. .......................................3481Laservision ...................................................1130LC Cell .........................................................3287LEO Pharma Inc. ................................2827, 3211LIFTLAB Skin Regeneration .........................2787Light Age Inc. ...............................................1433LightScalpel ..................................................3504Lilly USA, LLC ....................................3435, 3545Lipotec USA Inc. ...........................................1013LIPSMART ...................................................1074Locks of Love Inc. .........................................1308
Lumenis .......................................................2541Lutronic ........................................................2867
MMartiDerm ...................................................1060Mastocytosis Society Inc., The .......................1291Mayne Pharma .............................................1481Mayo Clinic ..................................................1193McGraw-Hill Education .................................3291MCV Physicians-VCU Health ........................1693md:ceuticals ..................................................3387MedCo Data ..................................................3368Medesthetics Magazine .................................2785Medicol USA ................................................1032Medimetriks Pharmaceuticals .......................1207MEDWEB .....................................................1366Melanoma Foundation of NE/
Brightguard ..............................................3589Mentholatum Co., The ..................................3515Mercedes Medical .........................................3269Merz .............................................................3015Mesoestetic SL ..............................................2680MetaOptima Technology Inc. ........................2684Microsurgery Instruments Inc. ......................2536Midmark Corp. .............................................2727Miraca Life Sciences ......................................2575Miramar Labs Inc. ........................................1035Mission Pharmacal Co. .................................1975MJD Patient Comm/
TopDocs.com ............................................2523Modernizing Medicine Inc. ...........................2665MoleSafe ......................................................1774MolluscumRx. ..............................................1006Mother To Baby Pregnancy Studies
conducted by OTIS....................................1329MTI Inc. .......................................................3343Mylan Inc. ....................................................3563Myriad Genetic Laboratories Inc. ...................1052
NNanbu Plastics Co. Ltd. .................................1282National Biological Corp. ...............................2453Nelly De Vuyst Derme & Co. .........................3261NeoGraft.......................................................3520NeoStrata Co. Inc. .........................................1539Neutrogena ...................................................2505New Beauty Magazine ...................................1331New Medical Technology Inc. ........................1974NEWPONG CO. Ltd. .....................................3581NewSurg .......................................................1008Nextech ........................................................2417NextGen Healthcare ......................................3519NIA24 ..........................................................1290NIAMS .........................................................2327NoIR LaserShields ........................................1327NovaCutis Inc. ..............................................1577Novartis Pharmaceuticals Corp. .. 1627, 1635, 1937Novella Clinical .............................................1367Novoxel Ltd. ..................................................1080Nutrafol ........................................................1012NY LASER OUTLET .....................................1016
OOculo-Plastik Inc. .........................................1118OCuSOFTSkin Care ......................................3260Officite .........................................................1674Omni Bioceutical Innovations .......................3381Omnilux .......................................................3559Ontos Inc. .....................................................1011Otto Trading Inc. ................................1027, 1270Outcome Health ...........................................1075Oxygenetix Institute Inc. ...............................1875
PPalmer’s .......................................................2969
Continued on page 16
NEW
Novartis Pharmaceuticals CorporationEast Hanover, New Jersey 07936-1080 Printed in USA © 2017 Novartis 2/17 T-COS-1340535
Novartis acts in accordance with the PhRMA Code on Interactions With Health Care Professionals. The PhRMA Code states that inclusion of a health care professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high quality learning environment for all participating health care professionals. Thank you.
This program is independent and is not part of the of� cial AAD Annual Meeting, as planned by its Scienti� c Assembly Committee. This program does not qualify for continuing medical education (CME) credit.
Cyndi Lauper
Featured Patient:
Jeffrey Weinberg, MD
Presented by:DINNER SYMPOSIUMSunday, March 5, 20176:30 PM – 7:00 PM Registration 7:00 PM – 10:00 PM ProgramOrange Ballroom E-G • Hilton Orlando • Orlando, FLPlease arrive at 6:30 PM to register.Dinner will be provided.
Hear Cyndi Lauper’s Story
This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presenters are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.
Expert Rheumatologist Sergio Schwartzman, MD
Expert Dermatologist Paul Yamauchi, MD, PhD
Presented by:INDUSTRY EXPERT SESSIONSaturday, March 4, 201710:45 AM – 11:00 AM Registration11:00 AM – 11:45 AM ProgramIndustry Expert Theater inside Exhibit HallOrange County Convention Center - West • Orlando, FLPlease arrive at 10:45 AM to register.Lunch will be provided.
Hear Expert Insights on What’s Possible With COSENTYX
Join us for these exciting eventsat this year’s AAD Annual Meeting!
CELEBRATING OUR HISTORY AT BOOTH #1635
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201716
FullPage.indd 1 2/1/17 11:31 AM
PatientPoint ..................................................1014Payspan Inc. .................................................1084PCA Skin ......................................................1253Peninsula Medical .........................................3191PerfAction Technologies ...............................3089Perigee .........................................................1581Perimed Inc. .................................................2379Perrigo .........................................................3264Person & Covey .............................................1668Pfizer Inc. .....................................................2589Philips Respironics .......................................3533PhotoMedex ..................................................2135PhytoCeuticals Inc. .......................................3163Pierre Fabre USA ..........................................3041Practical Dermatology ...................................3062Precision Medical Devices LLC ......................1287PRIME Journal .............................................1030ProCell Therapies .........................................3570Procter & Gamble .........................................2231Proinnovera GmbH ......................................1091Promius Pharma...........................................1461Promoitalia Group S.P.A. ..............................1386ProPath Dermatopathology ...........................2027PSI/Vanicream Skin Care ..............................2127Psoria-Shield Inc. ..........................................1068
QQuanta USA .................................................3063Quantificare ..................................................2474Quintessence Skin Science ............................3130
RRa Medical Systems Inc. ................................2567Refine USA ...................................................2482Regen Lab .....................................................3407Regeneron/Sanofi Genzyme ..........................3175
RegimenMD LLC ..........................................1266Restoration Robotics .....................................3239Revision Skincare .........................................1241Riverchase Dermatology................................3591Robbins Instruments ....................................1304Rohrer Aesthetics LLC ...................................2791Rose Micro Solutions ......1126, 1930, 2064, 3445
SSamumed LLC ..............................................3537Sanford Health .............................................3267SanovaWorks (including JDD) .......................3320SanSoleil...Sun Care You Can Wear... .............1593Sawgio LLC ...................................................2880Scar Heal ......................................................2174Schweiger Dermatology Group ......................3523SciBase .........................................................1120Sciton ...........................................................1819SCS Direct Inc. .............................................3513Sebamed USA...............................................3286Sebela Pharmaceuticals Inc. ..........................3365Sensus Healthcare ........................................2275Sente ............................................................3567Sesderma ......................................................1313SESHA Skin Therapy ....................................3410Shantel Medical Supply .................................2623SharpLight Technologies Ltd. ........................3314Shenzhen GSD Tech Co. Ltd. ........................1278SILAB...........................................................3486Sinclair Pharma ............................................2989Skin ..............................................................1017Skin & Cancer Associates/
Advanced Dermatology Mgmt ...................2963Skin Cancer Foundation, The ........................3221Skin Disease Education Foundation ..............1771SkinCeuticals ................................................1653SkinGen International Inc. ............................1020SmartPractice ...............................................2823Society of Dermatology Physician Assistants ..3315
Solumbra by Sun Precautions ........................3353Solutionreach................................................3528Sterilis LLC ...................................................3571Stiefel, a GSK company .................................1389STRATA Skin Sciences .................................2035StrataDx .......................................................1961Stratpharma Switzerland ...............................1182Sun Pharma ..................................................3127Sun Products ................................................2741Sun Protection Zone .....................................3031Suneva Medical .............................................1667SurgiTel/General Scientific Corp. ..................2271Swiss-American Mfg. & Product
Development ............................................2834Symbio LLC ..................................................3406Syneron Candela ...........................................2953Syris Scientific ..............................................3404
Ttaberna pro medicum ....................................2227Tender Corp. .................................................1293Teoxane Laboratories ....................................1088Tergus Pharma LLC ......................................3564Theradome Inc. ............................................3557Thermi .........................................................3081ThermoTek Inc. ............................................2175Tiemann-Bernsco..........................................2405Tilley Endurables ..........................................2922Tizo by Fallene Ltd. .......................................1719TKL Research ...............................................1065Topix Pharmaceuticals Inc. ...........................2019Total Clinical Trial Management ....................3590
UUnder Skin ...................................................2722Unilever .......................................................2835United Skin Specialists .................................3487Unity Point Health-Methodist Proctor ...........1589
University of Florida Health Pathology Laboratorie ................................3489
UV Skinz Inc. ...............................................3369UVBIOTEK ..................................................1591
VValeant Pharmaceuticals
North America LLC ...................................2005Venus Concept USA Inc. ...............................1121Viscot Medical LLC .......................................2274VisualDx .......................................................3544Vivacare ........................................................1671Viveve Inc. ....................................................3465Viviscal Professional .....................................1082VivoSight ......................................................1475Vydence Medical ...........................................1031
WWallaroo Hat Co............................................1569West-TeleVox Solutions .................................1619Wiley ............................................................2060Wolters Kluwer .............................................1529WON TECH Co. Ltd. .....................................2883
X-YXoft-a subsidiary of iCAD Inc. .......................3413XTETIC ........................................................2975Young Pharmaceuticals Inc. ..........................1553
ZZELTIQ .......................................................1231Zero Gravity .......................................1087, 3586Zimmer Medizin Systems .............................1361ZO Skin Health Inc. ......................................2069Zocular .........................................................3469
Continued from page 12
PREPARED BY FCB
Job #: 10687590Releasing as: Native file Production: S. Curry x3029
Colors: 4C AD: C. Anderson
Client: Pfizer AE:
Product: Eucrisa Bleed: 11.125”w x 15.25”h Producer: L. Burgess
Client Code: Trim: 10.875"w x 15"h QC: L.Powell
Date: January 19, 2017 5:44 PM Safety: 10.375"w x 14.5"w Digital Artist: tp,BD, tp, BB, tp,BD
Proof: M6FRAdd’l Info:
Fonts: Co Text M1 Spellcheck: M. Benedetto
FR Spellcheck: Luigi Mennella
Path: PrePress:Pfizer:Eucrisa:10687590:_PACKAGED:10687590_AAD_Annual_Mtg_News:10687590_AAD_Annual_Mtg_News_M6FR
4C Eucrisa AAD Annual Meeting News Ad
AAD food court
Entrance to convention hall
at booth #2589
Now Approved!Connect•the•dots to learn more
PP-CRI-USA-0201 © 2017 Pfizer Inc. All rights reserved. Printed in USA/January 2017
S:10.375”S:14.5”
T:10.875”T:15”
B:11.125”B:15.25”
10687590_AAD_Annual_Mtg_News_M6FR.indd 1 1/19/17 5:52 PM
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201718
Tips for closing surgical defects to be presentedBy Terrence A. Cronin Jr., MDSession Director
D ermatologists from the Florida Society of Dermatologic Surgeons will make four presentations
during a Saturday session on new and better ways to close surgical defects from skin cancer removal:• “Creating the Ideal
Linear Closure,” Jonathan Kantor, MD
• “Surgical Approaches to Multiple Cutaneous Carcinomas,” Terrence A. Cronin Sr., MD
• “Rotation Flaps: How They Work and Where to Put Them,” Andrew Weinstein, MD, MPH
• “Maximizing Your Dermatologic Surgery Outcomes,” Susan Weinkle, MD
A lot of the innovations in wound closure develop among those dermatologic surgeons deep in the trenches of treating the skin cancer epidemic. Whether it’s new suture material, stitching techniques, or new flaps and grafts, I’m pleased that
these Florida experts are presenting their pearls and advancements to our AAD audience. Certainly, all attendees will improve their surgical knowledge and be able to help their skin cancer
patients more effectively.Material covered by speakers will
include:• New research data that shows
advances in suturing techniques• New methods that were effective and
elegant for treating multiple wounds at the same time
• New surgical methods for closing skin cancer wounds effectively and cosmetically
Nanotechnology may be used to deliver natural immunomodulatory and anti-neoplastic ingredients
A dam Friedman, MD, will present “Nanotechnology and Immunomodulators” during a Sunday session. He
is an associate professor of dermatology, residency program director, and director of translational research at George Washington University School of Medicine and Health Sciences in Washington, D.C.
Q: What is the focus of your presentation?A: I will present new data on how nanomaterials can effectively deliver and use natural ingredients that have the potential to greatly impact both inflammatory and neoplastic diseases of the skin.
Q: What natural agents will you discuss in your presentation?A: 1. Curcumin, which is the polyphenol that gives the Indian spice tumeric its yellow color and numerous medical benefits, from wound healing to cancer.
2. Sanguinerine, which is the active ingredient in blood root made notorious by internet-based, dangerous skin tag removal products, which, when used correctly, has potent anti-melanoma properties. 3. Chitosan, which is a structural carbohydrate derived from the chitin in crustacean exoskeleton that has potent anti-acne, anti-inflammatory, and anti-microbial properties. 4. Cannabinoids, which are the chemical compounds THC and CBD secreted by cannabis flowers that confer an ever-emerging array of therapeutic properties, including pain control, anti-inflammation, and anti-neoplasia. These and many other naturally occurring medicinal ingredients are unified by a common thread; they are inherently unstable and difficult to deliver through and to the intended target — the skin.
Q: How does nanotechnology factor into this?A: Nanotechnology is the science of really really small. How small? One-billionth of a meter. Nano-sized materials can be designed
and tailored to stabilize, target, and deliver these multifaceted agents in ways that have never been accomplished in the past. Through nanotechnology, the translation from plant to person can be realized.
Q: Why is nanotechnology so important in using these agents?A: Our ability to capitalize on the unique
properties of many naturally derived ingredients is hindered by their poor bioavailability, stability, and cosmesis. Nanotechnology can be tailored to overcome all of these limitations and enable us to translate the wealth of bench research on ingredients such as curcumin, sanguinerine, and even cannabinoids to the bedside.
Filler complications: BlindnessBy Katie Beleznay, MDVancouver, BC, Canada
N ew research on complications from filler treatments, the most serious of which is related
to injecting into the blood vessels with the possible resulting complication of blindness, will be presented in an education session Sunday.
In the world literature to date, there are at least 98 cases of blindness from fillers. Only one of those cases had complete vision recovery, so this complication is most commonly irreversible. To highlight the significance of this issue, the Food and Drug Administration recently issued a safety communication about the risk of intravascular injection with fillers.
One of the most important preventive steps is knowing the location of blood
vessels and the proper depth of injection for the filler, so the session will review the relevant facial anatomy and shared treatment strategies, as well as a protocol that physicians should implement if they run into one of these unfortunate complications.
Other presentations:• Legal Issues of Filler Complications • Infection, Sensitivity, Granulomas• Vascular Compromise• Peri-orbital• Global Filler Complications• Cheeks/Mid-Face• Lips/Chin/Oral Commissure• Dorsal Hands• Temple/Forehead• Database of Filler Complications
Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics (F120)
3:30-5:30 p.m. Sunday
Room W307D
Adam Friedman, MD
Breaking News
Avoiding and Managing Filler Complications (C023)
1-4 p.m. Sunday
Room W415A
Breaking News
Wound Closure Design: Basic to Advanced (F078)
1-3 p.m. Saturday
Room W307D
ROZATROL™
Treatment For Red, Sensitized Skin
zoskinhealth.com
Decrease in severity of rosacea, flushing and redness symptoms at six weeks.
BASELINE 6 WEEKS
BASELINE 6 WEEKS
Nearly 80% of rosacea patients reported having to use more than one medication to manage the condition.*
Rozatrol™ features a multiplex of ingredients to relieve the multiple symptoms known to be associated with rosacea. All in One Tube.
THE BEST SOLUTION ISONE SOLUTION
PATENT PENDINGCLINICALLY PROVEN
VISIT US AT BOOTH #2069*Independent third party study of 22 subjects to assess the efficacy potential of Rozatrol™ in minimizing the signs and symptoms of Rosacea. Subjects were evaluated at 2, 4, and 6 weeks with the following protocol AM and PM: Oilacleanse™, Rozatrol™ and Oclipse-C™ SPF 50 in the AM. *Source: National Rosacea Society Survey
©2017 AbbVie Inc. North Chicago, IL 60064 64V-1896028 January 2017 Printed in U.S.A.
Learn more at Booth 2053
64V-1896028_2017_AAD_DailyNews_Plum.indd 1 1/18/17 1:46 PM
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 2017 21
©2017 AbbVie Inc. North Chicago, IL 60064 64V-1896028 January 2017 Printed in U.S.A.
Learn more at Booth 2053
64V-1896028_2017_AAD_DailyNews_Plum.indd 1 1/18/17 1:46 PM
Breaking News
Preliminary data from VIP trialsStudies explore relationship between skin, coronary disease
T he negative effect of skin disease on vascular disease is the focus of several recent studies.
Data from two of those studies, the Vascular Inflammation in Psoriasis (VIP) trial and its related extension trial, VIP-E, as well as an observational cohort study, the Psoriasis Atherosclerosis Cardiometabolic Initiative (PACI), will be discussed Saturday during “Biologics: Perils and Promise.”
Two presentations in the session will look at the initial information from the VIP trial and PACI study, each using simultaneous imaging modalities, positron emission tomography (PET) and computed tomography (CT) to better understand the relationship between skin disease and vascular disease in patients with psoriasis, said Nehal N. Mehta, MD, MSCE. He will present “Imaging Vascular Diseases in Psoriasis” and Joel M. Gelfand, MD, MSCE, will present “Impact of Psoriasis Biologics on Cardiovascular Risk: Relevance for Clinical Practice.”
“We are going to show preliminary data about how treatments of skin disease may impact aortic vascular inflammation detected by PET/CT.
Dr. Gelfand will introduce preliminary results, and I will follow up with longitudinal data from our NIH
cohort,” said Dr. Mehta, chief of the Section of Inflammation and Cardiometabolic Disease at the National Institutes of Health.
VIP is a randomized, controlled trial with three arms that used FDG PET/CT to study the effects of
adalimumab versus phototherapy versus placebo on the primary outcome of aortic vascular inflammation at 12 weeks. VIP-E examined the results in those patients at 52 weeks. VIP and VIP-E are the first in a series of trials about the effects of skin disease on coronary arteries. Other ongoing trials are looking at the effects of ustekinumab and secukinumab, Dr. Mehta said.
Other presentations during the session:• “Unique Clinical Scenarios in
Psoriasis”• “Update on New and Emerging
Psoriasis Medications”• “Biosimilars: Clinical Study
Design, Extrapolation, and Interchangeability”
• “The Risk of Infection and Malignancy With Biologic Therapy”
Biologics: Perils and Promise (S030)
1-4 p.m. Saturday
Room W415A
Tips to keep your patients relaxed
I n the course of everyday work, people become creative, finding ways to save time and get better results. Friday, four dermatologists
regaled a large, interested audience as they reviewed favorite tips — from working positions to folding drapes to helping patients relax — during “Simple Tricks and Practical Tips to Optimize the Surgical Experience for You and Your Patients.”
Charlene Lam, MD, MPH, kicked off the discussion on a technical note by showing images of closure techniques
she relies on in difficult situations. This included the purse string, which she said she likes to use on skin with laxity, concavities, ears, the scalp, and full-thickness graft donor sites.
Dr. Lam also advised on the importance of correct positioning. A surgeon who is in an uncomfortable position may hurry through a procedure, which takes a toll on the body and could lead to medical complications in the patient. It is best to stand straight and look down at the patient with the head
See TIPS page 25
Amping up social media
Charlene Lam, MD, MPH, discusses the usefulness of wound closure procedures Friday during “Simple Tricks and Practical Tips to Optimize the Surgical Experience for You and Your Patients.”
Annual Meeting attendees posed for a fun selfie Friday at the AAD Resource Center in The Connection, in Hall B4. Stop by the Selfie Station to take part in the fun. The first 200 attendees to participate will have an opportunity to take home a free selfie stick.
Patient Encounter sessions dealing with “Medication Management,” “The Difficult Patient,” “Breaking Bad
News,” and “Total Body Skin Exam” will take place throughout the Annual Meeting. The sessions give attendees an opportunity to focus on a specific topic and learn new skills or hone skills they already use in practice.
Visit www.aad.org/meetings/annual-meeting for availability.
Patient Encounters
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201722
AAD’s Skin Condition of the Day
The winner will receive a $25 Starbucks gift
card from AAD.
Text* “AAD Saturday” and your answer to 80802.
One winner will be selected from all correct texts received by 2 p.m. Saturday.
Identify this skin
condition and win!
The correct answer to yesterday’s Skin Condition of the Day is: Seborrheic Keratosis. For more information, go to SKMatters.com
Thank you to all of the participants. Congratulations to Katie Keel, Midstate Skin Institute in Ocala, Florida, recipient of the $25 Starbucks gift card.
Support for this program is being provided by Aclaris Therapeutics, Inc.
Today’s answer is available at
Aclaris Therapeutics, Inc. (Booth 3526) and will be published in tomorrow’s
edition of Dermatology World Meeting News
Images provided by Visual Dx
* Standard message rates apply
H alf of women in their 20s deal with the physical and emotional scarring of acne, and many have turned to
using spironolactone as a treatment, but it is associated with side effects. New evidence has been published about how to best deal with those side effects.
Spironolactone is an antiandrogen that is effective in controlling hormonal cystic/scarring breakouts in patients with acne within three months. However, physicians are concerned about the possibility of elevated blood potassium levels in patients using greater doses of spironolactone, said Shari Marchbein, MD. Other side effects include irregular menses and breast tenderness.
Dr. Marchbein, assistant professor of clinical dermatology at New York University Langone School of
Medicine, will discuss the use of spironolactone during a Saturday session, “Practical Guidelines for Using Spironolactone in Acne Patients.”
“There is a paucity of literature regarding the appropriate use, safety, and monitoring guidelines for spironolactone,” she said. “A 2015 article in JAMA Dermatology has given strong evidence that periodic blood monitoring to check for elevated serum potassium
levels is not warranted. “Most patients do not experience any
abnormalities during spironolactone therapy. This is helpful in that it saves the patient from unnecessary blood draws, as well as saving health care dollars on unneeded tests.”
Other presentations during the session will address using spironolactone for treatments other than acne, such as high blood pressure and edema.
Breaking News
Practical Guidelines for Using Spironolactone in Acne Patients (F075)
1-3 p.m. Saturday
Room W208A
Blood monitoring not needed in acne treatment
Allergic dermatitis in children
C onventional wisdom long has suggested that allergic dermatitis is uncommon in children. The reality is,
children suffer from allergic dermatitis as frequently as adults. The most common culprits are chemicals in personal care products.
“There are over 4,000 chemicals that we are exposed to on a daily basis, and only 35 of them are acknowledged by the Food and Drug Administration as allergens,” said Sharon E. Jacobs, MD, professor of dermatology at Loma Linda University and founder/CEO of The Dermatitis Academy, an online information resource for patients and parents. “Children with persistent allergic contact dermatitis need patch testing just as much as adults do.”
Dr. Jacobs explored the current realities of allergic contact dermatitis in children Friday during “The Truth About Pediatric Contact Dermatitis” (U009). Data from the Pediatric Contact Dermatitis Registry found that 48 percent of children tested were contact sensitized with 65 percent clinical relevance—rates nearly identical to published adult data.
More recent data from a survey of 252 pediatric providers found that children with allergic dermatitis are 17 times more likely to have a positive patch test than children without allergic dermatitis and 110 times more likely to have generalized involvement.
“We need to test more children,” Dr. Jacobs said. “We are missing a lot of patients who need serious help. Patients with allergic dermatitis have a history of dermatitis for 3.5 years compared to 1.8 years for other patients.”
Pediatric patch test studies identified the top allergens as: neomycin, balsam of Peru, fragrance mixes, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone (MCI)/methylisothiazolinone (MI), propylene glycol, and benzalkonium chloride.
Other common pediatric allergens include detergents, parthenolide/compositae, nickel, cobalt, colophene, chromates, glucoside, and p-phenylenediamine, or PPD.
Those agents are commonly used in fragrances, cleaning products, cell phones, metal furniture, jewelry, foods, henna, medications, personal care, and other products commonly found in homes, schools, daycare centers, and parents’ skin.
A third of toys have been found to release nickel and cobalt. Toilet seats in schools and other public areas may be cleaned with harsh detergents and incompletely rinsed, causing allergic reactions. Black henna tattoos are a common source of allergens and should never be applied to children. Glucoside is found in many personal care products, including infant sunscreens.
“One of the most common sources of allergens is cosmetics, fragrances, hair dyes, and personal products used by parents,” Dr. Jacobs said. “Sometimes finding the source takes some sleuthing. It can be as obvious as a new rubber mat in a daycare center or as elusive as glue used in a bra or shoes.”
One of the most effective steps to treat allergic dermatitis is to remove the allergen. Pre-emptive avoidance strategy (PEAS) can effectively cure about one-third of children with persistent allergic dermatitis.
Avoidance may mean removing the product from the environment, such as offensive fragrance. It may also mean protecting items that cannot be avoided, such as putting duct tape over the rubber on soccer shin guards that are emitting allergens.
Pick up the Experience guideThe Experience AAD in Orlando onsite meeting guide is available in racks throughout the convention center. It has all of the vital information about the meeting:• How to navigate AAD 2017• Daily highlights• AAD honors and awards• Education information• Exhibit hall floor plan and exhibitors• Convention center maps• City information
Sharon E. Jacobs, MD: “There are over 4,000 chemicals that we are exposed to on a daily basis, and only 35 of them are acknowledged by the Food and Drug Administration as allergens.”
Current contributors at time of publication.
THANK YOU!
In Recognition of Our
2017 AAD ANNUAL MEETING SUPPORTERSThe American Academy of Dermatology gratefully acknowledges the following Corporate Partners
for providing support of the Academy’s 2017 AAD Annual Meeting.
Through their generosity, we are able to provide the following:
2017 AAD Annual MeetingOrlando, FloridaMarch 3-7, 2017ORANGE COUNTY CONVENTION CENTER
Annual Meeting News Post Edition Level A
Annual Meeting News Preview Edition Level A
Hotel Key Cards
Mobile App
Pocket Guide
™
Advance Registration Mailer
Sharing Mentoring Experiences Breakfast
Partial Support:
Resident Access to Education Program at Annual Meeting
Attendance Verification Monitors
E-Posters Exhibit Area
Leadership and Mentoring Reception
Press Office and Media Appreciation Luncheon
Residents’ Lunch (Thursday)
International Member ReceptionNetworking Center
WiFi
Residents’ Reception (Friday)
Young Physician and New Member Reception
Meeting Concierge Program Vests
Residents’ Reception (Thursday)Stars of the Academy Awards Reception
Partial Support:
World Congress Scholarships
Annual Meeting News Preview Edition Level B
Partial Support:
Resident Access to Education Program at Annual Meeting
Untitled-1 1 2/2/2017 3:25:16 PM
EXPERIENCE • EXPLORE • INTERACTat the
AAD Resource Center in Hall B4
✓ ✓
✓✓
✓✓
• Come take your #AAD17 selfie! The first 200 attendees to post get a FREE selfie stick.
• Discover AAD’s Practice Management Center which features the latest resources designed to help you navigate the ever-changing practice environment.
• FREE professional headshots. HEADSHOT SCHEDULE:
Friday, March 3 10 a.m. – 5 p.m. Saturday, March 4 10 a.m. – 5 p.m. Sunday, March 5 12 p.m. – 5 p.m. Monday, March 6 10 a.m. – 5 p.m.
• Don’t forget our expert staff and Affinity Partners will be on-hand to assist you.
• 10% off select AAD products.
• Receive $50 off your 2017 MIPS reporting plus a FREE gift with DataDerm™ enrollment.
• Pre-order and save $50 on the 2017 Annual Meeting On-Demand Recordings.
• 20% off one AAD product, see coupon below.
SHOP & SAVEWHAT’S NEW
SAVE AT THE AAD RESOURCE CENTER
20% OFFONE AAD PRODUCT*
* Offer only valid at the AAD Resource Center 3/3/2017 – 3/6/2017. Present this coupon at time of purchase. Coupon may only be used once and cannot be used on already discounted or previously purchased items. Discount excludes taxes, shipping and handling, meeting registration, membership dues, DermCare Team enrollment fees, JAAD subscription and third-party products. AMRC17
Present this coupon and get
Friday, March 3 – Monday, March 68 a.m. – 5 p.m. daily
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 2017 25
OFTHE NEXT GENERATION
HEALING OINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENTOINTMENT
CeraVe is a registered trademark of Valeant Pharmaceuticals International, Inc. or its affiliates. All other product/brand names and/or logos are trademarks of the respective owners.
©2017 Valeant Pharmaceuticals North America LLC. CVE.0232.USA.16
CeraVe Healing Ointment
Aquaphor Healing Ointment
Petrolatum base 46.5% 41.0%
Ceramides 1, 3, & 6-II
Contains dimethicone
Accepted by the National Eczema Association
Lanolin free
Fragrance free
Dye free
CeraVe is widely available at these and other retailers:
Its unique formulation is hypoallergenic, non-comedogenic, and protects and soothes the skin.
NON-GREASY FEEL
EXPERIENCE • EXPLORE • INTERACTat the
AAD Resource Center in Hall B4
✓ ✓
✓✓
✓✓
• Come take your #AAD17 selfie! The first 200 attendees to post get a FREE selfie stick.
• Discover AAD’s Practice Management Center which features the latest resources designed to help you navigate the ever-changing practice environment.
• FREE professional headshots. HEADSHOT SCHEDULE:
Friday, March 3 10 a.m. – 5 p.m. Saturday, March 4 10 a.m. – 5 p.m. Sunday, March 5 12 p.m. – 5 p.m. Monday, March 6 10 a.m. – 5 p.m.
• Don’t forget our expert staff and Affinity Partners will be on-hand to assist you.
• 10% off select AAD products.
• Receive $50 off your 2017 MIPS reporting plus a FREE gift with DataDerm™ enrollment.
• Pre-order and save $50 on the 2017 Annual Meeting On-Demand Recordings.
• 20% off one AAD product, see coupon below.
SHOP & SAVEWHAT’S NEW
SAVE AT THE AAD RESOURCE CENTER
20% OFFONE AAD PRODUCT*
* Offer only valid at the AAD Resource Center 3/3/2017 – 3/6/2017. Present this coupon at time of purchase. Coupon may only be used once and cannot be used on already discounted or previously purchased items. Discount excludes taxes, shipping and handling, meeting registration, membership dues, DermCare Team enrollment fees, JAAD subscription and third-party products. AMRC17
Present this coupon and get
Friday, March 3 – Monday, March 68 a.m. – 5 p.m. daily
and neck at an angle between 15 and 40 degrees.
A survey by the American College of Mohs Surgery showed that 90 percent of medical respondents reported some form of musculoskeletal symptoms or injuries, Dr. Lam said. The most common problem areas were the neck (65 percent), lower back (63 percent), shoulders (61 percent), and upper back (53 percent).
Allison Vidimos, MD, RPh, chairman of the department of dermatology at Cleveland Clinic, provided tips ranging from local anesthesia to protecting against eye injuries when using lasers.
For local anesthesia, Dr. Vidimos prefers to improve the patient experience by using lidocaine to begin numbing slowly before using bupivacaine. She then recommends using acetaminophen postoperatively to reduce pain.
Lasers are a danger to the eyes of both patients and health care professionals, so wearing goggles is vital, she said. It is also important to wear different goggles for different types of lasers. Dr. Vidimos recommended marking them clearly, even using color-coded dots on goggles to match dots on the equipment.
Finally, Dr. Vidimos warned the audience about Aschner reflex, in which a patient’s pulse rate can decrease when traction is applied to the ocular muscles or when the eyeball is compressed. She said she became aware of this reflex when a patient coded during a minor procedure she was observing.
Following Dr. Vidimos to the dais was Elizabeth M. Billingsley, MD, who talked about the importance of using drapes. She advocates for the liberal use of drapes to keep sutures and equipment sterile by keeping them from touching tables and chairs during a procedure.
Dr. Billingsley said she asks patients if they are claustrophobic before beginning a procedure because some patients can become anxious when covered by drapes.
“Make sure the patient can breathe, and if you cover the eyes, don’t push on the eyeballs,” said Dr. Billingsley, a professor of dermatology at Penn State Hershey Medical Center.
Marc D. Brown, MD, professor of dermatology and oncology at the University of Rochester, described processes his office uses to keep surgical patients relaxed.
“Stress impairs wound healing by as much as 40 percent,” he said. He urged keeping patients as stress-free as possible, including answering questions from anxious patients following the procedure.
TIPS, continued from page 21 SUNSCREEN, continued from page 1
• Several agents used in sunscreens outside the U.S. could potentially improve sunscreen effectiveness. The Food and Drug Administration has indicated that it needs more data on these ingredients before they can be approved for use, but Dr. Rigel hopes this will be re-evaluated
• Allergies to sunscreen occur in less than 1 percent of the population. Most issues attributed to allergies are actually a reaction to fragrance or using a heavy
sunscreen that may cause acne.• The FDA recommends more studies
on the impact of zinc nanoparticles in sunscreen.
• Sunscreens with antioxidants often may have added sub-therapeutic levels so that they may have little impact on UV protection.
• When using insect repellants and sunscreen, apply the repellant first so absorption into the skin can be minimized.
• Getting a base tan does not help reduce the risks of sun exposure.
• Sunscreen may break down in excessive temperatures, such as in cars parked in the sun in the summer heat, where the temperature can exceed 150 degrees. It remains stable in 100-degree weather on the beach.
The best sunscreen? — “The one people will actually apply and use on a regular basis,” Dr. Rigel said.
To learn more about sunscreen ingredients that have not yet been approved by the FDA, visit www.aad.org/dw/monthly/2016/may/ a-recipe-for-public-health.
DERMATOLOGY WORLD MEETING NEWS • SATURDAY • MARCH 4, 201726
Product Spotlight
Get social with the AAD on Facebook and Twitter
A re you following @AADmember on Twitter? If not, we encourage you to join the 7,500+ other followers who get exclusive
updates about the Annual Meeting and share their photos with the AAD for all members to enjoy. See the best selfies from the Selfie Station in the AAD Resource Center by following the @AADmember feed today!
Be sure to also like the new Facebook page designed specifically for AAD Members (@AADmember), which will also be updating followers with news and
information about the Annual Meeting, including posts about new and popular sessions, special events, tourist information, and, of course, shared photos of members and attendees enjoying the meeting.
To share your photos with the AAD, use the official meeting hashtag #AAD17 in all your posts and tweets to engage in conversations and activities throughout the meeting.• Facebook: www.facebook.com/
AADmember • Twitter: www.twitter.com/AADmember
Promotional Offer Booth 2274
www.viscot.com800.221.0658
BOTOX® is a registered trademark of Allergan Inc.
Marking Consultations
Botox®
Injectable Fillers
E•Z Removable Ink™ Skin Marker
Promotional Offer:Booth 2274
Promotional Offer:Booth 2274
So�zone® Syringe TraySingle hand capping of needles
www.viscot.com800.221.0658
Naturally, you want a cold sore to go away fast. Naturally, it can. The secret? Sarracenia. A plant-based SuperBotanical™ that’s been proven to work wonders. Aubio’s exclusive formula works fast to get you back to your beautiful, smiling self. How fast? In a recent study, 100% of Aubio cold sore gel users said they’d use it again.
That fast.
aubío.com
Dermatologist developed. Cools and soothes. Ultra-effective botanicals. As nature intended.
gel users said they’d use it again.
That fast.
Goodbye, cold sore. Hello, beautiful.
Nature’s golden drop.™
AUBI 20909-AdCampaign-2.38x3.18 .indd 1 2/10/2017 1:58:20 PM
Make payment easier at every age and through every stage.
AAD Annual Meeting, Booth #1127 800-300-3046 • carecredit.com
AADTS0317CA
4279 AAD 2.375x3.125 V3.indd 1 2/10/17 3:03 PM
For the latest information on program titles, times, locations, and registration go to
aad.org/incprograms.
Don’t miss out on attending Industry Non-CME (INC) Programs being held in the evening from March 2 – March 5, 2017, in Orlando, FL. At the sponsoring company’s discretion, these programs may be promotional or educational in nature.
Programs are held conveniently at the Hyatt Regency Orlando and/or Hilton Orlando, and cover a range of topics.
These informational programs do not qualify for CME credit, and all content is under the control of the sponsoring company. These events are independent and are not part of the official AAD Annual Meeting as planned by the Scientific Assembly Committee. Pre-registration may be recommended by the sponsoring companies.
Attend an Industry Non-CME (INC) Program
Untitled-1 2 2/2/2017 3:25:17 PM
Meet the AAD Board of Directors
AAD President-Elect Henry Lim, MD, (left) talks with an Annual Meeting attendee Friday in The Connection, in Hall B4. Members of the AAD Board of Directors will be back at The Connection from noon to 1 p.m. today to meet with members. Light refreshments will be served.
This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presented are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.
Sponsored by Celgene
Shane Chapman, MDDartmouth Hitchcock DermatologyLebanon, New Hampshire
Moving Beyond Topicals: Perspectives on Systemic Treatment for Psoriasis
I N D U S T R Y E X P E R T S E S S I O N
Friday, March 3, 2017 / 11:00 AM –11:45 AM / Exhibit FloorOrange County Convention Center / Orlando, Florida
This Industry Expert Session is a promotional activity and is not approved for continuing education credit. The content of this session and opinions expressed by presenters are those of the Presenting Company or presenters and do not represent an endorsement by, nor imply that the products have been evaluated or approved by the American Academy of Dermatology.
Pursuant to the PhRMA Code on Interactions with Healthcare Professionals, attendance at this promotional program is restricted to healthcare professionals. Accordingly, spouses and other guests who are not healthcare professionals may not attend this event. Celgene will report transfers of value made to US healthcare professionals to the extent required by federal and state laws, as applicable. To learn about how Celgene Corporation complies with the Physician Payments Sunshine Act visit http://www.celgene.com/about/compliance/sunshine-act/.
© Celgene Corporation 12/16 USII-CELG160070To register, scan the QR code to your mobile device, or visit
http://www.celgenepsoriasisprogram.com
You’re invited to join the discussion!
PROGRAM FACULTY